Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molecular Partners Ag (MOLN) Current Leases: 2020-2024

Historic Current Leases for Molecular Partners Ag (MOLN) over the last 5 years, with Dec 2024 value amounting to $1.4 million.

  • Molecular Partners Ag's Current Leases fell 13.47% to $1,530 in Q3 2025 from the same period last year, while for Sep 2025 it was $1,530, marking a year-over-year decrease of 13.47%. This contributed to the annual value of $1.4 million for FY2024, which is 50735.58% up from last year.
  • According to the latest figures from FY2024, Molecular Partners Ag's Current Leases is $1.4 million, which was up 50,735.58% from $2,721 recorded in FY2023.
  • Molecular Partners Ag's Current Leases' 5-year high stood at $1.4 million during FY2024, with a 5-year trough of $2,721 in FY2023.
  • Its 3-year average for Current Leases is $463,293, with a median of $3,791 in 2022.
  • Per our database at Business Quant, Molecular Partners Ag's Current Leases crashed by 99.60% in 2021 and then soared by 50,735.58% in 2024.
  • Yearly analysis of 5 years shows Molecular Partners Ag's Current Leases stood at $1.3 million in 2020, then plummeted by 99.60% to $5,260 in 2021, then fell by 27.93% to $3,791 in 2022, then declined by 28.22% to $2,721 in 2023, then surged by 50,735.58% to $1.4 million in 2024.